Cibc Asset Management Inc Exact Sciences Corp Transaction History

Cibc Asset Management Inc

  • $28.3 Billion
  • Q3 2024

A detailed history of Cibc Asset Management Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Cibc Asset Management Inc holds 6,489 shares of EXAS stock, worth $372,338. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,489
Previous 6,118 6.06%
Holding current value
$372,338
Previous $258,000 70.93%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$42.43 - $70.83 $15,741 - $26,277
371 Added 6.06%
6,489 $441,000
Q2 2024

Aug 01, 2024
BUY
$41.33 - $74.26 $14,713 - $26,436
356 Added 6.18%
6,118 $258,000
Q1 2024

May 09, 2024
BUY
$56.27 - $73.77 $675 - $885
12 Added 0.21%
5,762 $397,000
Q4 2023

Feb 13, 2024
SELL
$59.06 - $75.72 $25,513 - $32,711
-432 Reduced 6.99%
5,750 $425,000
Q3 2023

Oct 30, 2023
BUY
$65.94 - $99.04 $6,725 - $10,102
102 Added 1.68%
6,182 $421,000
Q2 2023

Aug 14, 2023
BUY
$62.68 - $95.05 $250 - $380
4 Added 0.07%
6,080 $570,000
Q1 2023

May 12, 2023
BUY
$47.19 - $70.77 $4,341 - $6,510
92 Added 1.54%
6,076 $412,000
Q4 2022

Feb 13, 2023
SELL
$30.35 - $53.15 $53,780 - $94,181
-1,772 Reduced 22.85%
5,984 $296,000
Q3 2022

Nov 03, 2022
BUY
$31.97 - $49.37 $703 - $1,086
22 Added 0.28%
7,756 $252,000
Q2 2022

Aug 09, 2022
SELL
$35.61 - $76.23 $402,677 - $862,008
-11,308 Reduced 59.38%
7,734 $305,000
Q1 2022

May 06, 2022
BUY
$57.56 - $82.54 $647,204 - $928,079
11,244 Added 144.19%
19,042 $1.33 Million
Q4 2021

Feb 08, 2022
BUY
$72.5 - $100.68 $59,812 - $83,061
825 Added 11.83%
7,798 $607,000
Q3 2021

Nov 09, 2021
BUY
$90.24 - $124.05 $92,044 - $126,531
1,020 Added 17.13%
6,973 $666,000
Q2 2021

Aug 16, 2021
BUY
$93.66 - $139.27 $1,685 - $2,506
18 Added 0.3%
5,953 $740,000
Q1 2021

May 14, 2021
BUY
$116.57 - $155.01 $55,254 - $73,474
474 Added 8.68%
5,935 $782,000
Q3 2020

Nov 05, 2020
BUY
$72.92 - $102.01 $9,844 - $13,771
135 Added 2.53%
5,461 $557,000
Q1 2020

Apr 30, 2020
SELL
$37.9 - $104.44 $15,197 - $41,880
-401 Reduced 7.0%
5,326 $309,000
Q4 2019

Feb 14, 2020
BUY
$77.66 - $99.74 $79,989 - $102,732
1,030 Added 21.93%
5,727 $530,000
Q3 2019

Oct 30, 2019
BUY
$90.37 - $122.49 $36,238 - $49,118
401 Added 9.33%
4,697 $424,000
Q2 2018

Aug 09, 2018
BUY
$37.84 - $69.96 $162,560 - $300,548
4,296 New
4,296 $257,000

Others Institutions Holding EXAS

# of Institutions
674
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email